Carlton Haywood Jr
Overview
Explore the profile of Carlton Haywood Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1783
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lanzkron S, Little J, Wang H, Field J, Shows J, Haywood Jr C, et al.
Ann Intern Med
. 2021 Jul;
174(9):1207-1213.
PMID: 34224261
Background: Patients with sickle cell disease (SCD) have vaso-occlusive crises (VOCs). Infusion centers (ICs) are alternatives to emergency department (ED) care and may improve patient outcomes. Objective: To assess whether...
2.
Bae S, Johnson M, Massie A, Luo X, Haywood Jr C, Lanzkron S, et al.
Clin J Am Soc Nephrol
. 2021 Feb;
16(3):407-414.
PMID: 33632759
Background And Objectives: Patients with sickle cell disease-associated kidney failure have high mortality, which might be lowered by kidney transplantation. However, because they show higher post-transplant mortality compared with patients...
3.
Ogunsile F, Bediako S, Nelson J, Cichowitz C, Yu T, Carroll C, et al.
Blood Cells Mol Dis
. 2018 Nov;
74:25-29.
PMID: 30391047
Metabolic syndrome (MetS) is a key risk factor for cardiovascular disease (CVD) incidence and all-cause mortality. MetS prevalence among adults with sickle cell disease (SCD) is not well known. We...
4.
Naik R, Smith-Whitley K, Hassell K, Umeh N, De Montalembert M, Sahota P, et al.
Ann Intern Med
. 2018 Nov;
169(9):619-627.
PMID: 30383109
Background: Although sickle cell trait (SCT) is largely a benign carrier state, it may increase risk for certain clinical outcomes. Purpose: To evaluate associations between SCT and clinical outcomes in...
5.
Goddu A, OConor K, Lanzkron S, Saheed M, Saha S, Peek M, et al.
J Gen Intern Med
. 2018 Oct;
34(1):164.
PMID: 30338470
In the HTML version of this paper, Ms. Goddu was incorrectly listed. The correct citation should be AP Goddu. Exposure to the stigmatizing language note was associated with more negative...
6.
Lanzkron S, Little J, Field J, Shows J, Wang H, Seufert R, et al.
Blood Adv
. 2018 Sep;
2(18):2412-2417.
PMID: 30254105
The ESCAPED (Examining Sickle Cell Acute Pain in the Emergency vs Day Hospital) trial is an ongoing prospective study comparing outcomes of people with sickle cell disease (SCD) seeking care...
7.
Goddu A, OConor K, Lanzkron S, Saheed M, Saha S, Peek M, et al.
J Gen Intern Med
. 2018 Jan;
33(5):685-691.
PMID: 29374357
Background: Clinician bias contributes to healthcare disparities, and the language used to describe a patient may reflect that bias. Although medical records are an integral method of communicating about patients,...
8.
Carroll C, Haywood Jr C, Lanzkron S
South Med J
. 2016 Sep;
109(9):583-7.
PMID: 27598369
Objectives: Sickle cell disease (SCD) is associated with a high level of emergency department and hospital utilization, as well as a high rate of hospital readmissions. At Johns Hopkins Hospital,...
9.
Whiteman L, Haywood Jr C, Lanzkron S, Strouse J, Batchelor A, Schwartz A, et al.
South Med J
. 2016 Sep;
109(9):576-8.
PMID: 27598367
Objectives: Poor oral health can have a negative impact on overall health. This is especially concerning for individuals with sickle cell disease (SCD), an inherited blood disorder that affects hemoglobin...
10.
Cichowitz C, Carroll P, Strouse J, Haywood Jr C, Lanzkron S
South Med J
. 2016 Sep;
109(9):560-5.
PMID: 27598362
Objectives: Neurocognitive dysfunction is an important complication of sickle cell disease (SCD), but little is published on the utility of screening tests for cognitive impairment in people with the disease....